 BILLERICA, Mass.-- BUSINESS WIRE --Quanterix Corporation NASDAQ: QTRX, a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will be presenting at the 41st Annual J.P. Morgan Healthcare Conference. Quanterixs session will take place on Thursday, Jan. 12, 2023, at 12 p.m., PST and will be made available to attendees and the general public. In addition to the session, the company will also be hosting one-on-one meetings with institutional investors during the conference. 